Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 17, 2025 Off

Analysis of Guided Therapeutics’ FDA Study Data Reveals Compelling Clinical Need for LuViva

By BusinessWire

PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless…

December 17, 2025 Off

Galux Announces Research Agreement with Boehringer Ingelheim to Advance AI-Driven Protein Design

By BusinessWire

SEOUL, South Korea–(BUSINESS WIRE)–#AI—Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research…

December 17, 2025 Off

ZBiotics® Partners With the Snow Lodge & Après Ski Club in Aspen/Snowmass for Winter 2025–2026

By BusinessWire

First-of-its-kind hospitality partnership brings biotech-backed ‘social wellness’ to one of the world’s premier après destination resorts SAN FRANCISCO–(BUSINESS WIRE)–ZBiotics®, the…

December 17, 2025 Off

Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

By BusinessWire

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared…

December 17, 2025 Off

Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer

By BusinessWire

Company recognized for advancing ENV‑105, a first‑in‑class resistance‑modulating antibody for metastatic castration‑resistant prostate cancer LOS ANGELES–(BUSINESS WIRE)–Kairos Pharma Ltd. (NYSE…

December 17, 2025 Off

Valink Therapeutics and Nona Biosciences Form Strategic Alliance to Accelerate Novel Biologics Discovery

By BusinessWire

CAMBRIDGE, Mass. & LONDON–(BUSINESS WIRE)–Valink Therapeutics (“Valink”), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug…

December 17, 2025 Off

Autobahn Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced…

December 17, 2025 Off

Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead Metabolic Disease Strategy

By BusinessWire

ENV-308 is a first-in-class, once-daily oral therapy designed for chronic weight management, emphasizing high-quality weight loss with muscle mass preservation…

December 17, 2025 Off

NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy

By BusinessWire

— Submission supported by positive preliminary 18-month NAUTILUS data in patients with drug-resistant idiopathic generalized epilepsy (IGE) and generalized tonic-clonic…

December 17, 2025 Off

Avenacy to Attend J.P. Morgan 44th Annual Healthcare Conference

By BusinessWire

SCHAUMBURG, Ill.–(BUSINESS WIRE)–Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced that it will be attending…

Posts pagination

Previous 1 2 3 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine